ETX-19477: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
Advanced or Metastatic Solid Tumors	1
BRCA Mutation	1
BRCA1 Mutation	1
BRCA2 Mutation	1
Breast Cancer	1
Castrate Resistant Prostate Cancer	1
Colorectal Cancer	1
ER+ Breast Cancer	1
Endometrial Cancer	1
Epithelial Ovarian Cancer	1
Gastric Cancer	1
Ovarian Cancer	1
Prostate Cancer	1

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
NCT06395519 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 28 locations

1 recruiting trial across 13 conditions.

No. For the full record, search ClinicalTrials.gov.